Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Search results

Found 113 matches for

EMPA-KIDNEY is a clinical trial testing whether taking a single pill of empagliflozin every day prevents worsening of kidney disease or deaths from heart disease in people who have chronic kidney disease.

Will Herrington

Will Herrington

MA, MBBS, MD, MRCP Will Herrington - MRC-Kidney Research UK Professor David Kerr Clinician Scientist

Colin Baigent

Colin Baigent

Colin Baigent - Professor of Epidemiology and Director, MRC PHRU

Martin Landray

Martin Landray

FMedSci Martin Landray - Professor of Medicine and Epidemiology

David Preiss

David Preiss

PhD FRCPath MRCP David Preiss - Professor of Metabolic Medicine and Clinical Trials

Richard Haynes

Richard Haynes

DM, MRCP Richard Haynes - Professor of Renal Medicine and Clinical Trials